Allogene Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALLO and other ETFs, options, and stocks.

About ALLO

Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. 

CEO
David D. Chang
CEODavid D. Chang
Employees
229
Employees229
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2017
Founded2017
Employees
229
Employees229

ALLO Key Statistics

Market cap
254.69M
Market cap254.69M
Price-Earnings ratio
-0.88
Price-Earnings ratio-0.88
Dividend yield
Dividend yield
Average volume
5.85M
Average volume5.85M
High today
$1.29
High today$1.29
Low today
$1.00
Low today$1.00
Open price
$1.20
Open price$1.20
Volume
19.09M
Volume19.09M
52 Week high
$3.78
52 Week high$3.78
52 Week low
$0.8621
52 Week low$0.8621

Analyst ratings

79%

of 14 ratings
Buy
78.6%
Hold
21.4%
Sell
0%

People also own

Based on the portfolios of people who own ALLO. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.